Posts

Serious adverse effects of cannabidiol (CBD): a review of randomized controlled trials.

/by

Authors: Rafael G. dos Santos, Francisco S. Guimarães, José Alexandre S. Crippa, et al
Expert Opinion on Drug Metabolism & Toxicology, 9 April 2020
—
Introduction: Recent trials using cannabidiol (CBD) have shown that most acute and prolonged adverse effects of CBD are mild to moderate, with rare serious adverse effects (SAEs). This review focused on analyzing SAEs of CBD and their possible relation to drug-drug interaction…

Read more

Adverse effects of cannabidiol: a systematic review and meta-analysis of randomized clinical trials.

/by

Authors: Edward Chesney, Dominic Oliver, Alastair Green, Simina Sovi, Jack Wilson, Amir Englund, et al
Neuropsychopharmacology, 8 April 2020
—
Cannabidiol (CBD) is being investigated as a treatment for several medical disorders but there is uncertainty about its safety. We conducted the first systematic review and meta-analysis of the adverse effects of CBD across all medical indications. Double-blind randomized plac…

Read more